New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
BIB ETF · ProShares Ultra Nasdaq Biotechnology ETF
The BIB Exchange Traded Fund (ETF) is provided by ProShares. It is built to track an index: NASDAQ Biotechnology Index. This ETF provides synthetic exposure, by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap (i.e. a contract with a financial institution which delivers the return of the index). This share class generates a stream of income by distributing dividends.
Last update 3/13/2026, 1:30 PM UTC
LIVE
CLOSED
This fund is part ofLeveraged Equity1M perf.-3.63%
Last price
$78.64
1M perf.
-7.24%
1M flows
-€2.2M
AuM
€70M
E/R
1.19%
Rating
Not rated
ESG Consensus®
BIB
$78.64
Performance & flows
December 15, 2025 → March 13, 2026
Create a free account to view the flows graph
BIB
$78.63
-1.83%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -7.24% | -1.83% | +51.50% | +57.96% | -11.84% | -10.83% | -1.42% | -1.42% | |
| Flows |
Key fund info
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
Issuer
CUSIP
74347R214
ISIN
US74347R2141
AuM
€70M
E/R
1.19%
Replication rating
Not rated
ESG Consensus®
More details
NAV
3/13/2026
$78.63
1D NAV change
-1.01%
Dividend policy
Replication method
Indirect
Replication model
Unfunded swap
No. of holdings
N/A
Inception date
4/7/2010
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Trust
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseAdvertisement
Risk profile
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -1.83% | +51.50% | +57.96% | -11.84% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
ProShares
ProShares ID Card
Number of funds
163
Total AuM
€93.48B
Expense ratio range
0.13% - 12.07%
Average expense ratio
1.5079%
Top 5 funds by ProShares
| AuM | ||
|---|---|---|
TQQQ | ProShares UltraPro QQQ ETF | €21.8B |
IQMM | ProShares GENIUS Money Market ETF | €19.69B |
NOBL | ProShares S&P 500 Dividend Aristocrats ETF | €9.73B |
QLD | ProShares Ultra QQQ ETF | €8.11B |
SSO | ProShares Ultra S&P500 ETF | €5.38B |
Frequently asked questions about BIB
What does ProShares Ultra Nasdaq Biotechnology ETF, BIB, invest in?
BIB is a Passive ETF. This ETF provides leveraged exposure (2x) to US Equities.
Which benchmark or index does BIB replicate?
BIB tracks the NASDAQ Biotechnology Index - USD, through a unfunded swap replication method.
What is the Total Expense ratio (TER) of BIB?
BIB carries a total expense ratio (TER) of 1.19%, indicating the annual cost for holding the fund.
When was BIB launched?
BIB was introduced to the market on April 7, 2010. It trades on United States
Who is the ETF issuer of BIB?
ProShares Ultra Nasdaq Biotechnology ETF, BIB, is provided by ProShares. Learn more about ProShares here.
What is the current assets under management (AUM) of BIB?
BIB oversees €70M in assets as of March 13, 2026.
How has BIB performed lately?
Based on data from March 13, 2026, BIB returned -7.24% over the past month, -1.83% over the last three months and -1.42% year-to-date.
What are the latest inflows or outflows for BIB?
As of March 13, 2026, BIB recorded net flows of -€2.2M over the last month and -€2.2M year-to-date.
Does BIB distribute dividends?
BIB follows a distributing dividend policy, meaning it pays out income to investors. As of March 13, 2026, its 12-month trailing yield was 0.78%.
What is the base currency of BIB?
The base currency of BIB is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
